HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics AG (NBRV), sold 100,370 shares at $10.96 ($1.1M) on 2017-04-07, disclosed to the SEC on 2017-04-11.
Open-market sale of $1.1M NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.28 | 6,617 | $75K | 6.9% |
| 2 | $10.96 | 18,001 | $197K | 18.2% |
| 3 | $10.73 | 37,876 | $406K | 37.5% |
| 4 | $10.73 | 37,876 | $406K | 37.5% |
| Total | $10.81 avg | 100,370 | $1.1M | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |